Phoenix Molecular Designs Alternatives & Competitors
12 companies similar to Phoenix Molecular Designs — A clinical stage biopharmaceutical company designing precise cancer therapeutics...
Companies similar to Phoenix Molecular Designs
Sierra Oncology
We are on a mission to deliver transformative therapies that treat rare forms of cancer.
San Mateo, United States
Prescient Therapeutics
A clinical stage oncology company developing personalised medicine approaches to cancer; c...
Australia
PineTree Therapeutics Inc
Disruptive Innovations to Treat Unmet Therapeutic Needs in Oncology
Cambridge, United States
Eikon Therapeutics
Eikon is a late-stage clinical biopharmaceutical company dedicated to inventing and develo...
Millbrae, United States
Rival Readout
Competing with Phoenix Molecular Designs? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Apollomics
We are a biopharmaceutical company committed to the discovery and development of mono- and...
Foster City, United State...
ALX Oncology
ALX Oncology is a clinical-stage biotechnology company advancing cancer therapies by boost...
South San Francisco, Unit...
ORIC Pharmaceuticals Inc.
Overcoming Resistance In Cancer
South San Francisco, Unit...
Adastra Pharmaceuticals
Adastra is committed to transforming cancer care.
Princeton, United States
Bound Therapeutics
Safe and effective next generation RNA therapeutics
Cherry Hill, United State...
Lytix Biopharma
A clinical-stage immuno-oncology company developing proprietary oncolytic drugs as a novel...
Oslo, Norway
Sopherion Therapeutics
Innovating metastatic breast cancer treatment through advanced nanotechnology solutions.
GLG Pharma
Why Show the GSK Compound? Because the cancer cells become resistant. How? By STAT3! GLG's...
Jupiter, United States
About Phoenix Molecular Designs
Phoenix Molecular Designs is a clinical-stage biotechnology company founded in 2012, with a clear mission encapsulated in its slogan: "A clinical stage biopharmaceutical company designing precise cancer therapeutics to address unmet medical needs." The company is dedicated to developing small molecule kinase inhibitors...
Biopharmaceutical, Cancer Therapeutics, Precision Medicine, Triple Negative Breast Cancer, Kinase Inhibitors, Clinical-stage Biotechnology, Oncology, Breast Cancer, Drug Development, Clinical Trials, Personalized Medicine, Healthcare Innovation, Metastatic Breast Cancer, Biomedical Research
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Phoenix Molecular Designs: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Phoenix Molecular Designs on 12 Sep 2024. The 12 companies listed here were last checked between 26 Jul 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
